Commonwealth Equity Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
3,469
-146
-4% -$67.4K ﹤0.01% 2193
2026
Q1
$1.74M Sell
3,615
-17,486
-83% -$8.95M ﹤0.01% 2131
2025
Q4
$11.9M Buy
21,101
+17,698
+520% +$10M 0.02% 811
2025
Q3
$1.75M Buy
3,403
+909
+36% +$397K ﹤0.01% 2110
2025
Q2
$783K Sell
2,494
-224
-8% -$67.3K ﹤0.01% 2779
2025
Q1
$828K Buy
2,718
+139
+5% +$46.8K ﹤0.01% 2619
2024
Q4
$857K Sell
2,579
-539
-17% -$183K ﹤0.01% 2512
2024
Q3
$1.04M Sell
3,118
-1,222
-28% -$464K ﹤0.01% 2315
2024
Q2
$1.79M Buy
4,340
+32
+0.7% +$12.7K ﹤0.01% 1863
2024
Q1
$1.74M Buy
4,308
+1,055
+32% +$371K ﹤0.01% 1871
2023
Q4
$997K Buy
3,253
+488
+18% +$132K ﹤0.01% 2181
2023
Q3
$669K Buy
2,765
+465
+20% +$119K ﹤0.01% 2343
2023
Q2
$552K Buy
2,300
+787
+52% +$163K ﹤0.01% 2523
2023
Q1
$284K Buy
1,513
+336
+29% +$69.5K ﹤0.01% 3012
2022
Q4
$250K Buy
+1,177
New +$235K ﹤0.01% 3021

Other funds holding MEDP

Commonwealth Equity Services's MEDP Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Medpace (MEDP) stake by 4% in Q2 2026, selling an estimated $67.4K and leaving 3,469 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Commonwealth Equity Services first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.9M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Commonwealth Equity Services held 3,469 shares of Medpace worth $1.84M as of Q2 2026.
  • Commonwealth Equity Services sold 146 Medpace shares in Q2 2026, an estimated $67.4K.
  • Medpace made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2193 holding.
  • Commonwealth Equity Services first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Commonwealth Equity Services's Medpace position peaked at $11.9M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.